Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Milan Stock Exchange FF.MI

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' Equity for the year ending December 31, 2023: USD 140.12 M

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' Equity is USD 140.12 M for the year ending December 31, 2023, a -1.75% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' Equity for the year ending December 31, 2022 was USD 142.61 M, a -14.90% change year over year.
  • Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' Equity for the year ending December 31, 2021 was USD 167.59 M, a -2.71% change year over year.
  • Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' Equity for the year ending December 31, 2020 was USD 172.25 M, a 3.51% change year over year.
  • Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' Equity for the year ending December 31, 2019 was USD 166.42 M, a -2.52% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
Milan Stock Exchange: FF.MI

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

CEO Mr. Marco Francesco Eigenmann
IPO Date Oct. 19, 2016
Location Italy
Headquarters Via Berlino, 39
Employees 780
Sector Health Care
Industries
Description

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders and granules, capsules, tablets, film-coated tablets, effervescent granules, and hard gelatine capsules. The company also provides nutraceutical products comprising soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatin capsules for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company manufactures and trades in cosmetics products consisting of hair care, skin care, liquid detergents for personal hygiene, skin care emulsions, oral hygiene, deodorants, alcohol-based perfumery, bath and shower gel, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, and liquid soaps; medical surgical aids and medical devices; antiseptics for undamaged skin, hand gel, pre-injection, hydroalcoholic surfaces, and iodine; and orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. The company was founded in 1984 and is headquartered in Verdellino, Italy.

Similar companies

ORS.MI

Orsero S.p.A.

USD 13.03

0.92%

ESAU.MI

Esautomotion S.p.A.

USD 2.50

0.60%

AV.MI

Antares Vision S.p.A.

USD 3.25

0.29%

PHN.MI

Pharmanutra S.p.A.

USD 53.59

1.39%

StockViz Staff

January 15, 2025

Any question? Send us an email